脑血管纤维肌性发育不良的回顾性队列研究
结果显示多血管床受累和脑外血管并发症发生率高,中位随访47个月期间总死亡率为7%。
要点
- 86例患者中90%为女性,平均年龄64岁,67%为双侧病变。
- 41%出现脑血管并发症,以颈动脉夹层(11%)最常见。
- 80%患者病变累及超过1支血管,58%为多血管床纤维肌性发育不良。
核心结论
- 颈动脉纤维肌性发育不良患者多血管床受累、脑外血管并发症及遗传性血管病变的发生率高,需要仔细筛查和监测。
主要发现
- 86例患者中女性78例(90%),平均年龄64岁,白种人45/59(75%)。
- 临床表现:卒中/短暂性脑缺血发作54例(63%),症状性颅内动脉瘤6例(10%),其他神经系统症状14例(16%),偶然发现11例(13%)。
- 受累血管:颈动脉79例(92%),椎动脉19例(22%),两者合并15例(17%);双侧病变58例(67%)。
- 脑血管并发症35例(41%):颈动脉夹层11例(23%),颈动脉狭窄或闭塞8例(9%),颈动脉动脉瘤8例(9%),脑动脉瘤9例(11%),椎动脉动脉瘤/夹层2例(2%),颈动脉海绵窦瘘2例(2%)。
- 22例接受脑外影像检查的患者中,14例(60%)存在其他血管床纤维肌性发育不良:肾动脉8例(36%),其他内脏动脉4例(18%),主动脉2例(9%);另有4例(18%)存在肾、脾或下肢动脉的动脉瘤或夹层。
临床怎么用
- 59例(68%)患者接受密切监测下的保守治疗,19例(21%)需要颈动脉/脑血管干预,9例(10%)需要其他部位血管干预。
- 随访期间20例(23%)出现复发性脑血管事件(卒中/短暂性脑缺血发作、症状性浆果动脉瘤)。
- 中位随访47个月期间总死亡率为7%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fibromuscular dysplasia (FMD) is a rare vasculopathy for which limited data are available particularly from Europe. Our aim was to study the clinical characteristics of a regional cohort of carotid fibromuscular dysplasia patients to assess their clinical outcomes and the rate of vascular complications. METHODS: A retrospective cohort study of all cases of carotid/cerebrovascular FMD presenting to our regional vascular service (catchment population approximately 2 million), between 1998 and 2020. Imaging reports and patient case notes were screened using the keywords "FMD", "Fibromuscular Dysplasia", and "carotid". From case-note and imaging review, all relevant clinical data were extracted and the anatomical extent of vascular disease recorded. RESULTS: Eighty six patients with a diagnosis of cerebrovascular fibromuscular dysplasia were identified on imaging (31 computed tomography angiography, 46 magnetic resonance angiography, and 9 digital subtraction angiography) by a neurovascular radiologist. The mean age was 64 years, 78 (90%) patients were female, and 45/59 (75%) were Caucasian. Presenting clinical syndromes were Stroke/transient ischemic attack in 54 (63%) patients, symptomatic intracranial aneurysm in 6 (10%), and other neurological symptoms (headache/migraine, tinnitus) in 14 (16%), with 11 (13%) presenting incidentally. Six patients (7%) had a positive family history of FMD (2 patients) or other cerebrovascular event (4 patients: carotid dissection, intracerebral bleed, or stroke). Eight patients (9%) had a known or suspected hereditary connective tissue disorder (2 Ehlers-Danlos syndrome). Involved vessels were as follows: Carotid (mainly extracranial) in 79 (92%), vertebral 19 (22%), and a combination of these in 15 (17%) patients. Fifty eight (67%) patients had bilateral disease. Cerebrovascular complications were observed in 35 (41%) patients as follows: carotid dissection 11 (23%), carotid stenosis or occlusion 8 (9%), carotid aneurysm 8 (9%), cerebral aneurysm 9 (11%), vertebral aneurysm/dissection 2 (2%), and carotid-cavernous fistula 2 (2%). Of the 22 patients who had extracranial imaging, 14 (60%) had FMD affecting other beds-renal artery in 8 (36%) patients, other visceral arteries in 4 (18%), and aorta in 2 (9%). In addition, 4 (18%) patients had aneurysm or dissection affecting renal, splenic, and lower limb arteries. Overall, 67 (80%) patients had FMD affecting more than 1 vessel and 50 (58%) had multisite FMD (>/ = 2 vascular beds involved). Fifty nine (68%) patients were managed conservatively on close surveillance. Nineteen (21%) patients required carotid/cerebrovascular intervention and 9 (10%) required vascular intervention at other sites. Recurrent cerebrovascular events (stroke/transient ischemic attack, symptomatic Berry aneurysm) were seen in 20 (23%) patients. Overall mortality was 7% over a median follow-up period of 47 months. CONCLUSIONS: Carotid FMD patients have a high rate of multisite involvement, extracerebral vascular complications, and evidence of hereditary vasculopathy, requiring careful screening and surveillance.
引用
- Kythreotou A, Weerakkody RA, Koysombat K, et al. A Retrospective Cohort Study of Cerebrovascular Fibromuscular Dysplasia. Ann Vasc Surg. 2023. PMID: 36642164. doi:10.1016/j.avsg.2022.12.092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。